New vaccination plan 2022: Key points with…

The new vaccination calendar 2022 and the vaccination recommendations were published on April 20, 2022 by the Ministry of Solidarity and Health. We report here on the most important innovations before we come back to them in more detail in the coming days. In the meantime, changes to the text of the recommendations have been identified and highlighted in this annotated document by MyVaccines.

These new recommendations have been integrated into the tools using the MesVaccins.net vaccination decision support system (vaccination audit on MesVaccins, vaccination audit on the vaccination information service in the general version or in the version for healthcare professionals, electronic vaccination card).

As the vaccination recommendations against Covid 19 and the vaccines available against this disease are subject to change, health professionals are invited to consult the website of the Ministry of Health or the High Authority for Health. The Vaccination Information Service website also updates information on Covid 19 and its vaccination.

Vaccination recommendations in connection with travel and stays abroad are not included in the vaccination plan and are the subject of a separate opinion from the High Council for Public Health (HCSP). This advice is normally updated every year in May-June (see the latest recommendations here); In 2022, the health recommendations for travelers are to be updated in autumn.

1. New recommendations

Vaccination against whooping cough is recommended for pregnant women from the second trimester of pregnancy (primarily between the 20th and 36th week of amenorrhea) to ensure optimal protection for the newborn. This vaccination can be performed with a combined quadrivalent dTcaP vaccine (diphtheria-tetanus-poliomyelitis-pertussis) with reduced doses of diphtheria toxoid (d) and pertussis antigens (ca, for acellular pertussis); in practice, corresponding vaccines are available in France are the vaccines Repevax or Boostrixtetra.

Vaccination against invasive meningococcal serogroup B infection with Bexsero is recommended for all infants from the age of 2 months and before the age of 2 years with the following vaccination schedule: first dose at 3 months, second dose at 5 months and booster dose at 12 months (M3-M5-M12). Vaccination against meningococcal B is also recommended for people who are close to people who are at high risk of invasive meningococcal disease. A meningococcal B booster vaccination every 5 years is recommended for individuals at risk of continued exposure to severe meningococcal infection.

Seasonal flu vaccination is now recommended for workers who are exposed to swine and avian viruses at work. This vaccination is a collective protective measure aimed at preventing the transmission of human influenza viruses to animals and not an individual protective measure against zoological viruses of pigs or birds.

2. New indications

Marketed in France since September 1, 2021, the Trumenba vaccine is indicated for the active immunization of individuals from 10 years of age for the prevention of invasive meningococcal disease caused by meningococci Serogroup B, in individuals at increased risk of meningococcal infection and in individuals eligible for specific referrals. This vaccine is currently not covered by health insurance.

The Influvac Tetra influenza vaccine can now be used as part of the seasonal influenza vaccination strategy from the age of 6 months (and no longer than 3 years) according to its marketing authorization (AMM).

3. Regulatory News

3.1. Expansion of vaccination competence

Since the last seasonal flu vaccination campaign (2021-2022 flu season), community nurses and pharmacists have been able to vaccinate all adults, including those not covered by vaccination recommendations. Midwives, pharmacists and nurses are allowed to administer certain non-live vaccines to people aged 16 and over who are affected by the vaccination recommendations without prior medical prescription (see notification of April 26, 2022).

3.2. Prescription of vaccines by company doctors, with the exception of vaccinations in connection with the exercise of a profession

Vaccinations from the vaccination plan prescribed by a doctor or a school doctor are now reimbursed by the health insurance companies.

This new vaccination calendar was published during vaccination week (25ah May 2022). This event is an opportunity to promote vaccination to the general public, in particular through communication about the new vaccination calendar 2022 and through digital solutions such as the MesVaccins.net electronic vaccination card, which will be made available to all citizens and will provide personalized information on vaccination needs for a better vaccination, without defects or excesses. Steps to integrate the electronic vaccination card into the digital health space are underway.

Source: Ministry of Health.


Leave a Comment